VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+4.29%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$891M
AUM Growth
+$891M
(+688%)
Cap. Flow
+$760M
Cap. Flow
% of AUM
85.31%
Top 10 Holdings %
Top 10 Hldgs %
57.95%
Holding
371
New
107
Increased
50
Reduced
125
Closed
30
Top Buys
| 1 |
EQM
EQM Midstream Partners, LP
EQM
|
$78.1M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$77.3M |
| 3 |
MPLX
MPLX
|
$72.7M |
| 4 |
Marathon Petroleum
MPC
|
$61.2M |
| 5 |
ENLK
EnLink Midstream Partners, LP
ENLK
|
$43.2M |
Top Sells
| 1 |
Incyte
INCY
|
$9.28M |
| 2 |
ACGN
Aceragen, Inc. Common Stock
ACGN
|
$3.92M |
| 3 |
Vanguard Utilities ETF
VPU
|
$1.69M |
| 4 |
Vanguard Energy ETF
VDE
|
$1.3M |
| 5 |
iShares MSCI India ETF
INDA
|
$1.24M |
Sector Composition
| 1 | Energy | 74% |
| 2 | Healthcare | 7.58% |
| 3 | Utilities | 1.27% |
| 4 | Financials | 0.09% |
| 5 | Technology | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
NiSource
NI
$19.9B
| $680K | 0.07% | +27,295 | New | +$680K |
|
|
AKCA
77
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $680K | 0.07% | 19,429 -13,886 | -42% | -$486K |
|
|
TVRD
78
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $676K | 0.07% | 28,233 -20,190 | -42% | -$483K |
|
79
MediciNova
MNOV
$64.3M
| $675K | 0.07% | 54,054 -39,714 | -42% | -$496K |
|
80
Puma Biotechnology
PBYI
$254M
| $652K | 0.07% | 14,227 +975 | +7% | +$44.7K |
|
81
Lexicon Pharmaceuticals
LXRX
$400M
| $648K | 0.07% | 60,728 +4,092 | +7% | +$43.7K |
|
|
SJI
82
DELISTED
South Jersey Industries, Inc.
SJI
| $645K | 0.07% | +18,289 | New | +$645K |
|
83
Fidelity MSCI Information Technology Index ETF
FTEC
$15.1B
| $643K | 0.07% | 10,667 -342 | -3% | -$20.6K |
|
84
Adicet Bio
ACET
$59.9M
| $642K | 0.07% | 42,419 -31,151 | -42% | -$471K |
|
85
WEC Energy
WEC
$34.3B
| $640K | 0.07% | +9,591 | New | +$640K |
|
|
MRNS
86
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $640K | 0.07% | 63,966 -46,025 | -42% | -$460K |
|
87
Regenxbio
RGNX
$451M
| $638K | 0.07% | 8,452 -6,040 | -42% | -$456K |
|
|
XIFR
88
XPLR Infrastructure, LP
XIFR
$996M
| $638K | 0.07% | +13,149 | New | +$638K |
|
|
MDCO
89
DELISTED
Medicines Co
MDCO
| $638K | 0.07% | 21,335 +1,438 | +7% | +$43K |
|
90
BioCryst Pharmaceuticals
BCRX
$1.74B
| $637K | 0.07% | 83,470 -59,662 | -42% | -$455K |
|
91
Agios Pharmaceuticals
AGIO
$2.19B
| $634K | 0.07% | 8,215 +563 | +7% | +$43.5K |
|
|
MYOK
92
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $630K | 0.07% | 9,666 -6,914 | -42% | -$451K |
|
93
CMS Energy
CMS
$21.4B
| $628K | 0.06% | +12,807 | New | +$628K |
|
|
VLP
94
DELISTED
Valero Energy Partners LP
VLP
| $628K | 0.06% | +16,569 | New | +$628K |
|
95
Fate Therapeutics
FATE
$120M
| $621K | 0.06% | 38,094 -27,979 | -42% | -$456K |
|
96
Dominion Energy
D
$51.1B
| $619K | 0.06% | +8,811 | New | +$619K |
|
97
Dynavax Technologies
DVAX
$1.19B
| $610K | 0.06% | 49,231 +3,317 | +7% | +$41.1K |
|
98
Eversource Energy
ES
$23.8B
| $610K | 0.06% | +9,921 | New | +$610K |
|
99
Enanta Pharmaceuticals
ENTA
$180M
| $603K | 0.06% | 7,052 +475 | +7% | +$40.6K |
|
100
Verastem
VSTM
$569M
| $599K | 0.06% | 82,558 -60,630 | -42% | -$440K |
|